Megna R, Alfano B, Lanzillo R, Costabile T, Comerci M, Vacca G, Carotenuto A, Moccia M, Servillo G, Prinster A, Brescia Morra V, Quarantelli M
Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment
J Neurol (ISSN: 1432-1459electronic, 0340-5354linking, 0340-5354print), 2019 Feb; 266(2): 361-368.
Parisi V, Petraglia L, D'Esposito V, Cabaro S, Rengo G, Caruso A, Grimaldi MG, Baldascino F, De Bellis A, Vitale D, Formisano R, Ferro A, Paolillo S, Davin L, Lancellotti P, Formisano P, Perrone Filardi P, Ferrara N, Leosco D
Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue
Int J Cardiol (ISSN: 0167-5273, 1874-1754electronic, 0167-5273linking), 2019 Jan 1; 274: 326-330.
Lanzillo R, Quarantelli M, Pozzilli C, Trojano M, Amato MP, Marrosu MG, Francia A, Florio C, Orefice G, Tedeschi G, Bellantonio P, Annunziata P, Grimaldi LM, Comerci M, Brunetti A, Bonavita V, Alfano B, Marini S, Brescia Morra V
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2016 Aug; 22(9): 1163-1173.
Lanzillo R, Quarantelli M, Veria V, Orefice G, Marrosu MG, Trojano M, Amato MP, Francia AM, Florio C, Tedeschi G, Bellantonio P, Annunziata P, Comerci M, Brunetti A, Bonavita V, Alfano B, Marini S, Pozzilli C, Morra VB
Brain atrophy in relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic, 1351-5101linking), 2014 May; 119: 58-58.
Cefalo G, Massimino M, Ruggiero A, Barone G, Ridola V, Spreafico F, Potepan P, Abate ME, Mascarin M, Garrè ML, Perilongo G, Madon E, Colosimo C, Riccardi R
Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: An Italian multi-institutional phase II trial
Neuro-Oncology (ISSN: 1522-8517), 2014 May; 16(5): 748-753.
Lanzillo R, Quarantelli M, Veria V, Orefice G, Marrosu MG, Trojano M, Amato MP, Francia AM, Florio C, Tedeschi G, Bellantonio P, Annunziata P, Comerci M, Brunetti A, Bonavita V, Alfano B, Marini S, Pozzilli C, Morra VB
Brain atrophy in relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study)
J Neurol (ISSN: 0340-5354, 1432-1459, 0340-5354print), 2014; 140: S43-S43.
Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Saccà F, Marsili A, Quarantelli M, Brescia Morra V, Brunetti A, Carbone R, Pane C, Puorro G, Russo CV, Salvatore E, Tucci T, De Michele G, Filla A
A randomized clinical trial of lithium in multiple system atrophy
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 2013 Feb; 260(2): 458-461.
Giallauria F, Acampa W, Ricci F, Gallicchio R, Xhoxhi E, Vitelli A, D'Agostino M, Lucci R, Vigorito C, Cuocolo A
Effects of exercise training started within 2 weeks after acute myocardial infarction on myocardial perfusion and left ventricular function: A gated SPECT imaging study
Eur J Prev Cardiol (ISSN: 2047-4873, 2047-4881), 2012 Dec; 19(6): 1410-1419.
Brescia Morra V, Alfano B, Lanzillo R, Quarantelli M, Comerci M, Marini S, Vacca G, Amato MP, Trojano M, Brunetti A, Pozzilli C
Efficacy, safety and tolerability of Atorvastatin in patients with Relapsing-remitting multiple sclerosis in treAtment with INterferoN-beta (ARIANNA): a multicentre, randomised, double-blind, placebo-controlled, parallel-group-study
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2012 Oct; 18: 197-197.
Mancini M, Morra VB, Di Donato O, Maglio V, Lanzillo R, Liuzzi R, Salvatore E, Brunetti A, Iaccarino V, Salvatore M
Multiple sclerosis: cerebral circulation time
Radiology (ISSN: 1527-1315, 0033-8419, 1527-1315electronic), 2012 Mar; 262(3): 947-955.
Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A
Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection
Cell Tissue Res (ISSN: 0302-766x), 2012 Jan; 347(1): 291-301.
Esmaeilzadeh M, Kullingsjo J, Ullman H, Varrone A, Tedroff J
Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with huntington disease
Clin Neuropharmacol (ISSN: 0362-5664), 2011 May; 34(3): 95-100.
Lanzillo R, Orefice G, Quarantelli M, Rinaldi C, Prinster A, Ventrella G, Spitaleri D, Lus G, Vacca G, Carotenuto B, Salvatore E, Brunetti A, Tedeschi G, Brescia Morra V
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: A longitudinal controlled trial of combination therapy
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2010 Apr; 16(4): 450-454.
Imbriaco M, Pisani A, Spinelli L, Cuocolo A, Messalli G, Capuano E, Marmo M, Liuzzi R, Visciano B, Cianciaruso B, Salvatore M
Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study
Heart (ISSN: 1355-6037, 1468-201x), 2009 Jul; 95(13): 1103-1107.
Orefice G, Quarantelli M, Lanzillo R, Brunetti A, Salvatore P, Prinster A, Vacca G, Mollica C, Bonavita V, Morra VB, Prinster A
An open-label randomised clinical trial of atorvastatin in combination with IFN Beta 1a in active multiple sclerosis patients: preliminary results
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 2008 Jun; 255: N/D-N/D.
Orefice G, Quarantelli M, Salvatore P, Brunetti A, Lanzillo R, Prinster A, Vacca G, Mollica C, Bonauita V, Morra VB
Interferon beta-1a and atorvastatin combination therapy: 12-month results from an open-label, randomized, clinical study
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2008 Mar 11; 70(11): N/D-N/D.
Quarantelli M, Orefice G, Prinster A, Lanzillo R, Salvatore P, Mallica C, Salvatore E, Brunetti A, Alfano B, Morra VB
Is brain atrophy progression in RR-MS slowed by the association off atorvastatin and interferon beta-1a? Preliminary results from an open-label, randomized, clinical study
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2008 Mar 11; 70(11): N/D-N/D.
De Leva MF, Varrone A, Filla A, Quarantelli M, Bilo L, Piscitelli V, Salvatore E, Ammendola S, Striano S, De Michele G, Bonavita V, Pappata S
Neuroimaging follow-up in a case of Rasmussen's encephalitis with dyskinesias
Mov Disord (ISSN: 0885-3185, 1531-8257, 0885-3185linking), 2007 Oct 31; 22(14): 2117-2121.
Orefice G, Quarantelli M, Salvatore P, Brunetti A, Lanzillo R, Prinster A, Vacca G, Mollica C, Bonavita V, Morra VB
An open label randomised clinical trial of atorvastatin in combination with IFN beta-1a in active MS patients: 12 months results
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2007 Oct; 13: N/D-N/D.
De Simone G, Supuran CT
Antiobesity carbonic anhydrase inhibitors
Curr Top Med Chem (ISSN: 1568-0266, 1568-0266linking, 1873-4294electronic), 2007; 7(9): 879-884.
Biondi B, Palmieri EA, Pagano L, Klain M, Scherillo G, Salvatore M, Fenzi G, Lombardi G, Fazio S
Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer
J Clin Endocrinol Metab (ISSN: 0021-972x), 2003 Jan; 88(1): 211-214.